Danaher Corporation vs Gemini Space Station Inc — how do they compare? Danaher Corporation trades at $219.99 (market cap $152.87B), while Gemini Space Station Inc trades at $4.42 (market cap $579.55M). The key difference: Danaher Corporation is far larger — about 263.8× Gemini Space Station Inc's market cap, and Danaher Corporation pays a 0.74% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Gemini Space Station Inc for 14 Days on average.
| DHR | GEMI | |
|---|---|---|
Market Cap | $152.87B | $579.55M |
Volume | 5,228,698 | 1,882,406 |
Sector | Health | Financials |
52-Week High | $242.05 | $25.41 |
52-Week Low | $161.91 | $3.54 |
Typical Hold Time | 69 Days | 14 Days |
Enterprise Value | $175.08B | $558.57M |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Gemini Space Station (GEMI) trades at $4.43, down 1.34% on the day, with a bearish technical outlook despite recent price surges. The company reported Q2 2026 revenue growth of 37% year-over-year but continues to post significant losses, with a net income margin of -250.13%. Recent news highlights expansion into commission-free stock trading and prediction markets, though the stock faces headwinds from earnings misses and ongoing class action lawsuits.
The investment outlook remains high-risk due to persistent unprofitability and negative cash flow from operations. While analyst consensus suggests modest upside to a $5.25 price target, the stock's viability depends on achieving profitability amid competitive pressures and regulatory scrutiny. Current valuation metrics appear stretched given the company's fundamental challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →